Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asuransi Bina Dana Arta Tbk. (ABDA) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Asuransi Bina Dana Arta Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Asuransi Bina Dana Arta Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Asuransi Bina Dana Arta Tbk. trades at Rp3,830 (market cap 2.38T, 2K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Asuransi Bina Dana Arta Tbk. is far larger — about 7.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (41.7K versus 2K). Which is the better fit depends on your goals.

ABDADGNS
Market Cap
2.38T316.25B
Volume
2K41.7K
Lot
20417
Turnover
7.68M9.66M
Average Price
3,839.5231.65
Value
7.68M9.66M
Indicative Equilibrium Price
230
Indicative Equilibrium Volume
2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABDA
View details
DGNS
View details

About Asuransi Bina Dana Arta Tbk.

PT Asuransi Bina Dana Arta Tbk was established at Jakarta under the name of PT Asuransi Bina Dharma Arta, as in accordance with Notarial Deed No. 78 of Kartini Mulyadi, S.H., Notary in Jakarta, dated October 12, 1982.

Read more on ABDA

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS